Request a copy

Full Text

• S. Sun and X. S. Qiu, "Cancer stem cells and tumor metastasis" Journal of Cancer Research andTherapeutics, vol. 9, supplement, pp. S150-S152, 2013
• M. F. Clarke, J. E. Dick, P. B. Dirks et al., "Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells" Cancer Research, vol. 66, no. 19, pp. 9339-9344, 2006
• D. Hanahan and R.A. Weinberg, "The hallmarks of cancer" Cell, vol. 100, no. 1, pp. 57-70, 2000
• S. K. Singh, I. D. Clarke, M. Terasaki et al., "Identification of a cancer stem cell in human brain tumors" Cancer Research, vol. 63, no. 18, pp. 5821-5828, 2003
• L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi et al., "Identification and expansion of human colon-cancer-initiating cells" Nature, vol. 445, no. 7123, pp. 111-115, 2007
• C. E. Eyler and J. N. Rich, "Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis" Journal of Clinical Oncology, vol. 26, no. 17, pp. 2839-2845, 2008
• W. A. Woodward, M. S. Chen, F. Behbod, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen, "WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells" Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 2, pp. 618-623, 2007
• G. Rahmathulla, S. A. Toms, and R. J. Weil, "The molecular biology of brain metastasis" Journal of Oncology, vol. 2012, Article ID 723541, 16 pages, 2012
• C. Scheel and R. A. Weinberg, "Cancer stem cells and epithelialmesenchymal transition: concepts and molecular links" Seminars in Cancer Biology, vol. 22, no. 5-6, pp. 396-403, 2012
• T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, "Stem cells, cancer, and cancer stem cells" Nature, vol. 414, no. 6859, pp. 105-111, 2001
• S. Liu, Y. Cong, D. Wang et al., "Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts" StemCell Reports, vol. 2, no. 1, pp. 78-91, 2014
• N. Moro, C. Mauch, and P. Zigrino, "Metalloproteinases in melanoma" European Journal of Cell Biology, vol. 93, no. 1-2, pp. 23-29, 2014
• C. Lewis and C. Murdoch, "Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies" American Journal of Pathology, vol. 167, no. 3, pp. 627-635, 2005
• D. F. Quail and J. A. Joyce, "Microenvironmental regulation of tumor progression andmetastasis" Nature Medicine, vol. 19, no. 11, pp. 1423-1437, 2013
• B. Nieswandt, M. Hafner, B. Echtenacher, and D. N. Mannel, "Lysis of tumor cells by natural killer cells in mice is impeded by platelets" Cancer Research, vol. 59, no. 6, pp. 1295-1300, 1999
• P. S. Steeg, "Tumor metastasis:mechanistic insights and clinical challenges" Nature Medicine, vol. 12, no. 8, pp. 895-904, 2006
• L. J. Gay and B. Felding-Habermann, "Contribution of platelets to tumour metastasis" Nature Reviews Cancer, vol. 11, no. 2, pp. 123-134, 2011
• J. Grossmann, "Molecular mechanisms of 'detachment-induced apoptosis-Anoikis'" Apoptosis, vol. 7, no. 3, pp. 247-260, 2002
• Y. Kienast, L. Von Baumgarten, M. Fuhrmann et al., "Real-time imaging reveals the single steps of brain metastasis formation" Nature Medicine, vol. 16, no. 1, pp. 116-122, 2010
• J. P. Thiery, H. Acloque, R. Y. J. Huang, and M. A. Nieto, "Epithelial-mesenchymal transitions in development and disease" Cell, vol. 139, no. 5, pp. 871-890, 2009
• N. Ahmed, S. Maines-Bandiera, M. A. Quinn, W. G. Unger, S. Dedhar, and N. Auersperg, "Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium" The American Journal of Physiology-Cell Physiology, vol. 290, no. 6, pp. C1532-C1542, 2006
• V. Arnoux, M. Nassour, A. L'Helgoualc'h, R. A. Hipskind, and P. Savagner, "Erk5 controls slug expression and keratinocyte activation during wound healing"Molecular Biology of the Cell, vol. 19, no. 11, pp. 4738-4749, 2008
• E. Batlle, E. Sancho, C. Franci et al., "The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells" Nature Cell Biology, vol. 2, no. 2, pp. 84-89, 2000
• A. Eger, K. Aigner, S. Sonderegger et al., "DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells" Oncogene, vol. 24, no. 14, pp. 2375-2385, 2005
• J. Comijn, G. Berx, P. Vermassen et al., "The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion" Molecular Cell, vol. 7, no. 6, pp. 1267-1278, 2001
• M. A. Perez-Moreno, A. Locascio, I. Rodrigo et al., "A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions" Journal of Biological Chemistry, vol. 276, no. 29, pp. 27424-27431, 2001
• X. Wang, M. Zheng, G. Liu et al., "Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion" Cancer Research, vol. 67, no. 15, pp. 7184-7193, 2007
• J. Yang and R. A. Weinberg, "Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis" Developmental Cell, vol. 14, no. 6, pp. 818-829, 2008
• V. R. Sobrado, G. Moreno-Bueno, E. Cubillo et al., "The class I bHLH factors E2-2A and E2-2B regulate EMT" Journal of Cell Science, vol. 122, no. 7, pp. 1014-1024, 2009
• N. Dave, S. Guaita-Esteruelas, S. Gutarra et al., "Functional cooperation between snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition" The Journal of Biological Chemistry, vol. 286, no. 14, pp. 12024-12032, 2011
• Y. Wu, J. Deng, P. G. Rychahou, S. Qiu, B. M. Evers, and B. P. Zhou, "Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion" Cancer Cell, vol. 15, no. 5, pp. 416-428, 2009
• R. Dong, Q. Wang, X. L. He, Y. K. Chu, J. G. Lu, and Q. J. Ma, "Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-induced epithelial-mesenchymal transition of MCF-7 cells" Brazilian Journal of Medical and Biological Research, vol. 40, no. 8, pp. 1071-1078, 2007
• S. Thuault, E.-J. Tan, H. Peinado, A. Cano, C.-H. Heldin, and A. Moustakas, "HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition" The Journal of Biological Chemistry, vol. 283, no. 48, pp. 33437-33446, 2008
• Y. Yang, X. Pan, W. Lei, J. Wang, and J. Song, "Transforming growth factor-1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism" Oncogene, vol. 25, no. 55, pp. 7235-7244, 2006
• Y. Yang, X. Pan, W. Lei et al., "Regulation of transforming growth factor-1-induced apoptosis and epithelial-tomesenchymal transition by protein kinase A and signal transducers and activators of transcription 3" Cancer Research, vol. 66, no. 17, pp. 8617-8624, 2006
• C. Sahlgren, M. V. Gustafsson, S. Jin, L. Poellinger, and U. Lendahl, "Notch signaling mediates hypoxia-induced tumor cell migration and invasion" Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6392-6397, 2008
• M. H. Yang, M. Z. Wu, S. H. Chiou et al., "Direct regulation of TWIST by HIF-1alpha promotes metastasis" Nature Cell Biology, vol. 10, no. 3, pp. 295-305, 2008
• A. D. Yang, E. R. Camp, F. Fan et al., "Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells" Cancer Research, vol. 66, no. 1, pp. 46-51, 2006
• L. S. Wanami, H.-Y. Chen, S. Peiro, A. Garcia de Herreros, and R. E. Bachelder, "Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression" Experimental Cell Research, vol. 314, no. 13, pp. 2448-2453, 2008
• M.-Y. Lee, C.-Y. Chou, M.-J. Tang, and M.-R. Shen, "Epithelialmesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation" Clinical Cancer Research, vol. 14, no. 15, pp. 4743-4750, 2008
• V. Fendrich, J. Waldmann, F. Esni et al., "Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum" Endocrine-Related Cancer, vol. 14, no. 3, pp. 865-874, 2007
• M. Y. Maitah, S. Ali, A. Ahmad, S. Gadgeel, and F. H. Sarkar, "Up-regulation of sonic hedgehog contributes to TGF-1-induced epithelial to mesenchymal transition in NSCLC cells" PLoS ONE, vol. 6, no. 1, Article ID e16068, 2011
• J. I. Yook, X.-Y. Li, I. Ota et al., "A Wnt-Axin2-GSK3 cascade regulates Snail1 activity in breast cancer cells" Nature Cell Biology, vol. 8, no. 12, pp. 1398-1406, 2006
• J. M. Lopez-Nouoa and M. A. Nieto, "Inflammation and EMT: an alliance towards organ fibrosis and cancer progression" EMBO Molecular Medicine, vol. 1, no. 6-7, pp. 303-314, 2009
• M. Korpal, E. S. Lee, G. Hu, and Y. Kang, "The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2" Journal of Biological Chemistry, vol. 283, no. 22, pp. 14910-14914, 2008
• P. Samavarchi-Tehrani, A. Golipour, L. David et al., "Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming" Cell Stem Cell, vol. 7, no. 1, pp. 64-77, 2010
• C. G. Rao, D. Chianese, G. V. Doyle et al., "Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors" International Journal of Oncology, vol. 27, no. 1, pp. 49-57, 2005
• J. P. Thiery and J. P. Sleeman, "Complex networks orchestrate epithelial-mesenchymal transitions" Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131-142, 2006
• E. A. Runkle and D. Mu, "Tight junction proteins: from barrier to tumorigenesis" Cancer Letters, vol. 337, no. 1, pp. 41-48, 2013
• C. C. Warzecha, S. Shen, Y. Xing, and R. P. Carstens, "The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events" RNA biology, vol. 6, no. 5, pp. 546-562, 2009
• R. B. Hazan, R. Qiao, R. Keren, I. Badano, and K. Suyama, "Cadherin switch in tumor progression" Annals of the New York Academy of Sciences, vol. 1014, pp. 155-163, 2004
• M. B. Lustberg, P. Balasubramanian, B. Miller et al., "Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients" Breast Cancer Research, vol. 16, no. 2, article R23, 2014
• G. Barriere, A. Riouallon, J. Renaudie, M. Tartary, and M. Rigaud, "Mesenchymal characterization: alternative to simple CTC detection in two clinical trials" Anticancer Research, vol. 32, no. 8, pp. 3363-3370, 2012
• D. C. Radisky, D. D. Levy, L. E. Littlepage et al., "Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability" Nature, vol. 436, no. 7047, pp. 123-127, 2005
• C. Billottet, M. Tuefferd, D. Gentien et al., "Modulation of several waves of gene expression during FGF-1 induced epithelialmesenchymal transition of carcinoma cells" Journal of Cellular Biochemistry, vol. 104, no. 3, pp. 826-839, 2008
• S. Vega, A. V. Morales, O. H. Ocana, F. Valdes, I. Fabregat, and M. A. Nieto, "Snail blocks the cell cycle and confers resistance to cell death" Genes and Development, vol. 18, no. 10, pp. 1131-1143, 2004
• N.K. Kurrey, S. P. Jalgaonkar, A.V. Joglekar et al., "Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells" StemCells, vol. 27, no. 9, pp. 2059-2068, 2009
• S. Ansieau, J. Bastid, A. Doreau et al., "Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence" Cancer Cell, vol. 14, no. 1, pp. 79-89, 2008
• G. Z. Cheng, J. Chan, Q. Wang, W. Zhang, C. D. Sun, and L.-H. Wang, "Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel" Cancer Research, vol. 67, no. 5, pp. 1979-1987, 2007
• C. Kudo-Saito, H. Shirako, T. Takeuchi, and Y. Kawakami, "Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells" Cancer Cell, vol. 15, no. 3, pp. 195-206, 2009
• S. A. Mani, W. Guo, M.-J. Liao et al., "The epithelial-mesenchymal transition generates cells with properties of stemcells" Cell, vol. 133, no. 4, pp. 704-715, 2008
• V. Stemmer, B. de Craene, G. Berx, and J. Behrens, "Snail promotes Wnt target gene expression and interacts with-catenin" Oncogene, vol. 27, no. 37, pp. 5075-5080, 2008
• U. Wellner, J. Schubert, U. C. Burk et al., "The EMT-Activator ZEB1 promotes tumorigenicity by repressing stemnessinhibiting microRNAs" Nature Cell Biology, vol. 11, no. 12, pp. 1487-1495, 2009
• L. Hill, G. Browne, and E. Tulchinsky, "ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer" International Journal ofCancer, vol. 132, no.4, pp. 745-754, 2012
• M. Lu, M. K. Jolly, H. Levine, J. N. Onuchic, and E. Ben-Jacob, "MicroRNA-based regulation of epithelial-hybridmesenchymal fate determination" Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 45, pp. 18144-18149, 2013
• M. Todaro, M. Gaggianesi, V. Catalano et al., "CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis" Cell Stem Cell, vol. 14, no. 3, pp. 342-356, 2014
• V. L. Battula, Y. Shi, K. W. Evans et al., "Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis" The Journal of Clinical Investigation, vol. 122, no. 6, pp. 2066-2078, 2012
• M. M. Ho, A. V. Ng, S. Lam, and J. Y. Hung, "Side population in human lung cancer cell lines and tumors is enriched with stemlike cancer cells" Cancer Research, vol. 67, no. 10, pp. 4827-4833, 2007
• M. S. Sosa, P. Bragado, and J. A. Aguirre-Ghiso, "Mechanisms of disseminated cancer cell dormancy: an awakening field" Nature Reviews Cancer, vol. 14, no. 9, pp. 611-622, 2014
• D. M. Schewe and J. A. Aguirre-Ghiso, "ATF6-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo" Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10519-10524, 2008
• H. Jo, Y. Jia, K. K. Subramanian, H. Hattori, and H. R. Luo, "Cancer cell-derived clusterin modulates the phosphatidylinositol 3-kinase-Akt pathway through attenuation of insulinlike growth factor 1 during serum deprivation" Molecular and Cellular Biology, vol. 28, no. 13, pp. 4285-4299, 2008
• M. S. Sosa, A. Avivar-Valderas, P. Bragado, H.-C. Wen, and J. A. Aguirre-Ghiso, "ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease" Clinical Cancer Research, vol. 17, no. 18, pp. 5850-5857, 2011
• P. Bragado, M. S. Sosa, P. Keely, J. Condeelis, and J. A. Aguirre-Ghiso, "Microenvironments dictating tumor cell dormancy" Recent Results in Cancer Research, vol. 195, pp. 25-39, 2012
• Y. Shiozawa, A. M. Havens, K. J. Pienta, and R. S. Taichman, "The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites" Leukemia, vol. 22, no. 5, pp. 941-950, 2008
• A. Kobayashi, H. Okuda, F. Xing et al., "Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stemlike cells in bone" Journal of Experimental Medicine, vol. 208, no. 13, pp. 2641-2655, 2011
• H. Gao, G. Chakraborty, A. P. Lee-Lim et al., "The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites" Cell, vol. 150, no. 4, pp. 764-779, 2012
• G. Cheng, J. Tse, R. K. Jain, L. L. Munn, and M. V. Blagosklonny, "Micro-environmental mechanical stress controls tumor spheroid size andmorphology by suppressing proliferation and inducing apoptosis in cancer cells" PLoS ONE, vol. 4, no. 2, Article ID e4632, 2009
• C.M. Ghajar, H. Peinado, H. Mori et al., "Theperivascularniche regulates breast tumour dormancy" Nature Cell Biology, vol. 15, no. 7, pp. 807-817, 2013
• X. Lu, E. Mu, Y. Wei et al., "VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging 41-positive osteoclast progenitors" Cancer Cell, vol. 20, no. 6, pp. 701-714, 2011
• J. A. Aguirre-Ghiso, L. Ossowski, and S. K. Rosenbaum, "Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth" Cancer Research, vol. 64, no. 20, pp. 7336-7345, 2004
• P. Bragado, Y. Estrada, F. Parikh et al., "TGF-2 dictates disseminated tumour cell fate in target organs through TGF-RIII and p38/ signalling" Nature Cell Biology, vol. 15, no. 11, pp. 1351-1361, 2013
• C.-H. Wu, J. Van Riggelen, A. Yetil, A. C. Fan, P. Bachireddy, and D.W. Felsher, "Cellular senescence is an important mechanism of tumor regressionuponc-Myc inactivation" Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 104, no. 32, pp. 13028-13033, 2007
• I. Malanchi, A. Santamaria-Martinez, E. Susanto et al., "Interactions between cancer stem cells and their niche govern metastatic colonization" Nature, vol. 481, no. 7379, pp. 85-91, 2012
• N. Müller-Hermelink, H. Braumüller, B. Pichler et al., "TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promotemultistage carcinogenesis" Cancer Cell, vol. 13, no. 6, pp. 507-518, 2008
• A. D. Pardee, D. McCurry, S. Alber, P. Hu, A. L. Epstein, and W. J. Storkus, "A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment" Cancer Research, vol. 70, no. 22, pp. 9041-9052, 2010
• J. W. Franses, A. B. Baker, V. C. Chitalia, and E. R. Edelman, "Stromal endothelial cells directly influence cancer progression" Science Translational Medicine, vol. 3, no. 66, Article ID 66ra5, 2011
• C. A. Klein, "Framework models of tumor dormancy from patient-derived observations" Current Opinion in Genetics and Development, vol. 21, no. 1, pp. 42-49, 2011
• S. Kleffel and T. Schatton, "Tumor dormancy and cancer stem cells: two sides of the same coin? Advances in Experimental Medicine and Biology, vol. 734, pp. 145-179, 2013
• R. Demicheli, R. Miceli, A. Moliterni et al., "Breast cancer recurrence dynamics following adjuvantCMFis consistentwith tumor dormancy and mastectomy-driven acceleration of the metastatic process" Annals of Oncology, vol. 16, no. 9, pp. 1449-1457, 2005
• X. Li, M. T. Lewis, J. Huang et al., "Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy" Journal of the National Cancer Institute, vol. 100, no. 9, pp. 672-679, 2008
• P. E. Goss and A. F. Chambers, "Does tumour dormancy offer a therapeutic target? Nature Reviews Cancer, vol. 10, no. 12, pp. 871-877, 2010
• T. M. Phillips, W. H. McBride, and F. Pajonk, "The response of CD24-//CD44+ breast cancer-initiating cells to radiation" Journal of the National Cancer Institute, vol. 98, no. 24, pp. 1777-1785, 2006
• S. Bao, Q. Wu, R. E. McLendon et al., "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response" Nature, vol. 444, no. 7120, pp. 756-760, 2006
• A. P. Kusumbe and S. A. Bapat, "Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy" Cancer Research, vol. 69, no. 24, pp. 9245-9253, 2009
• N. Takebe, P. J. Harris, R. Q. Warren, and S. P. Ivy, "Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways" Nature Reviews Clinical Oncology, vol. 8, no. 2, pp. 97-106, 2011
• C. D. Lawton, D. T. Nagasawa, I. Yang, R. G. Fessler, and Z. A. Smith, "Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease: a review" Journal of Neurosurgery: Spine, vol. 17, no. 5, pp. 438-448, 2012
• G. Kalokhe, S. A. Grimm, J. P. Chandler, I. Helenowski, A. Rademaker, and J. J. Raizer, "Metastatic glioblastoma: case presentations and a review of the literature" Journal of Neuro-Oncology, vol. 107, no. 1, pp. 21-27, 2012
• M. Shahideh, A. Fallah, D. G. Munoz, and R. LochMacDonald, "Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinalmetastases, with two illustrative patients" Journal of Clinical Neuroscience, vol. 19, no. 8, pp. 1080-1086, 2012
• K. Onda, R. Tanaka, H. Takahashi, N. Takeda, and F. Ikuta, "Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy" Neurosurgery, vol. 25, no. 4, pp. 533-540, 1989
• F. T. Vertosick Jr. and R. G. Selker, "Brain stem and spinal metastases of supratentorial glioblastomamultiforme: a clinical series" Neurosurgery, vol. 27, no. 4, pp. 516-522, 1990
• W. H. Ng, T. T. Yeo, and A. H. Kaye, "Spinal and extracranial metastatic dissemination of malignant glioma" Journal of Clinical Neuroscience, vol. 12, no. 4, pp. 379-382, 2005
• T. N. Ignatova, V. G. Kukekov, E. D. Laywell, O. N. Suslov, F. D. Vrionis, and D. A. Steindler, "Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro" Glia, vol. 39, no. 3, pp. 193-206, 2002
• E. L. Jackson and A. Alvarez-Buylla, "Characterization of adult neural stem cells and their relation to brain tumors" Cells Tissues Organs, vol. 188, no. 1-2, pp. 212-224, 2008
• J. Godlewski, M. O. Nowicki, A. Bronisz et al., "Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits gliomaproliferation and self-renewal" Cancer Research, vol. 68, no. 22, pp. 9125-9130, 2008
• Y. Zhu, F. Guignard, D. Zhao et al., "Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma" Cancer Cell, vol. 8, no. 2, pp. 119-130, 2005
• S. K. Singh, C. Hawkins, I. D. Clarke et al., "Identification of human brain tumour initiating cells" Nature, vol. 432, no. 7015, pp. 396-401, 2004
• X. Yan, L. Ma, D. Yi et al., "A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations" Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 4, pp. 1591-1596, 2011
• R. M. R. Gangemi, F. Griffero, D. Marubbi et al., "SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity" Stem Cells, vol. 27, no. 1, pp. 40-48, 2009
• J. D. Lathia, J. Gallagher, J. M. Heddleston et al., "Integrin alpha 6 regulates glioblastoma stem cells" Cell Stem Cell, vol. 6, no. 5, pp. 421-432, 2010
• X. Jin, J. Yin, S.-H. Kim et al., "EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction" Cancer Research, vol. 71, no. 22, pp. 7125-7134, 2011
• F. T. Merkle, A. D. Tramontin, J. M. Garcia-Verdugo, and A. Alvarez-Buylla, "Radial glia give rise to adult neural stem cells in the subventricular zone" Proceedings of theNationalAcademy of Sciences of the United States of America, vol. 101, no. 50, pp. 17528-17532, 2004
• A. M. McCord, M. Jamal, U. T. Shankavarum, F. F. Lang, K. Camphausen, and P. J. Tofilon, "Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro" Molecular Cancer Research, vol. 7, no. 4, pp. 489-497, 2009
• X.-Z. Ye, S.-L. Xu, Y.-H. Xin et al., "Tumor-Associated microglia/macrophages enhance the invasion of glioma stemlike cells via TGF-1 signaling pathway" Journal of Immunology, vol. 189, no. 1, pp. 444-453, 2012
• N. J. Abbott, A. A. K. Patabendige, D.E.M. Dolman, S. R. Yusof, and D. J. Begley, "Structure and function of the blood-brain barrier" Neurobiology of Disease, vol. 37, no. 1, pp. 13-25, 2010
• S.-W. Lee, W. J. Kim, Y. K. Choi et al., "SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier" Nature Medicine, vol. 9, no. 7, pp. 900-906, 2003
• N. J. Abbott, L. Ronnback, and E. Hansson, "Astrocyteendothelial interactions at the blood-brain barrier" Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41-53, 2006
• L. G. Dubois, L. Campanati, C. Righy et al., "Gliomas and the vascular fragility of the blood brain barrier" Frontiers in Cellular Neuroscience, vol. 8, article 418, 2014
• S. Takano, T. Yamashita, andO. Ohneda, "Molecular therapeutic targets for glioma angiogenesis" Journal of Oncology, vol. 2010, Article ID 351908, 11 pages, 2010
• G. Bergers and L. E. Benjamin, "Tumorigenesis and the angiogenic switch" Nature Reviews Cancer, vol. 3, no. 6, pp. 401-410, 2003
• R. K. Jain, E. di Tomaso, D. G. Duda, J. S. Loeffler, A. G. Sorensen, and T. T. Batchelor, "Angiogenesis in brain tumours" Nature Reviews Neuroscience, vol. 8, no. 8, pp. 610-622, 2007
• A. Hirano and T. Matsui, "Vascular structures in brain tumors" Human Pathology, vol. 6, no. 5, pp. 611-621, 1975
• F. Winkler, Y. Kienast, M. Fuhrmann et al., "Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis" Glia, vol. 57, no. 12, pp. 1306-1315, 2009
• J. Holash, P. C. Maisonpierre, D. Compton et al., "Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF" Science, vol. 284, no. 5422, pp. 1994-1998, 1999
• S. Watkins, S. Robel, I. F. Kimbrough, S. M. Robert, G. Ellis-Davies, and H. Sontheimer, "Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells" Nature Communications, vol. 5, article 4196, 2014
• R. G. W. Verhaak, K. A. Hoadley, E. Purdom et al., "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1" Cancer Cell, vol. 17, no. 1, pp. 98-110, 2010
• H. S. Phillips, S. Kharbanda, R. Chen et al., "Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis" Cancer Cell, vol. 9, no. 3, pp. 157-173, 2006
• Y. Zhu, P. Ghosh, P. Charnay, D. K. Burns, and L. F. Parada, "Neurofibromas in NF1: Schwann cell origin and role of tumor environment" Science, vol. 296, no. 5569, pp. 920-922, 2002
• H. Colman, L. Zhang, E. P. Sulman et al., "Amultigene predictor of outcome in glioblastoma" Neuro-Oncology, vol. 12, no. 1, pp. 49-57, 2010
• C. E. Pelloski, A. Mahajan, M. Maor et al., "YKL-40expressionis associated with poorer response to radiation and shorter overall survival in glioblastoma" Clinical Cancer Research, vol. 11, no. 9, pp. 3326-3334, 2005
• M. S. Carro, W. K. Lim, M. J. Alvarez et al., "The transcriptional network for mesenchymal transformation of brain tumours" Nature, vol. 463, no. 7279, pp. 318-325, 2010
• K. P. L. Bhat, K. L. Salazar, V. Balasubramaniyan et al., "The transcriptional coactivator TAZ regulates mesenchymal differentiation inmalignant glioma" Genes and Development, vol. 25, no. 24, pp. 2594-2609, 2011
• K. P. Bhat, V. Balasubramaniyan, B. Vaillant et al., "Mesenchymal differentiationmediated byNF-kappaB promotes radiation resistance in glioblastoma" Cancer Cell, vol. 24, no. 3, pp. 331-346, 2013
• J. V. Joseph, V. Balasubramaniyan, A. Walenkamp, and F. A. E. Kruyt, "TGF-beta as a therapeutic target in high grade gliomas-promises and challenges" Biochemical Pharmacology, vol. 85, no. 4, pp. 478-485, 2013
• J.V. Joseph, S. Conroy, T. Tomar et al., "TGF-is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion" Cell Death and Disease, vol. 5, no. 10, article e1443, 2014
• J. V. Joseph, S. Conroy, K. Pavlov et al., "Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis" Cancer Letters, vol. 359, no. 1, pp. 107-116, 2015
• M. C. Elias, K. R. Tozer, J. R. Silber et al., "TWIST is expressed in human gliomas and promotes invasion" Neoplasia, vol. 7, no. 9, pp. 824-837, 2005
• F. J.N. Motta, E.T. Valera, A. K. B. Lucio-Eterovic et al., "Differential expression of E-cadherin gene in human neuroepithelial tumors" Genetics and Molecular Research, vol. 7, no. 2, pp. 295-304, 2008
• S.-P. Han, J.-H. Kim, M.-E. Han et al., "SNAI1 is involved in the proliferation and migration of glioblastoma cells" Cellular and Molecular Neurobiology, vol. 31, no. 3, pp. 489-496, 2011
• B. Lv, X. Yang, S. Lv et al., "CXCR4 signaling induced epithelialmesenchymal transition by PI3K/AKT and ERK pathways in glioblastoma" Molecular Neurobiology, 2014
• A. Liao, R. Shi, Y. Jiang et al., "SDF-1/CXCR4 axis regulates cell cycle progression and epithelial-mesenchymal transition via up-regulation of survivin in glioblastoma" Molecular Neurobiology, 2014
• P. Dahan, J. MartinezGala, C. Delmas et al., "Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance" Cell Death and Disease, vol. 5, Article IDe1543, 2014
• E. E. Bar, A. Lin, V. Mahairaki, W. Matsui, and C. G. Eberhart, "Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres" American Journal of Pathology, vol. 177, no. 3, pp. 1491-1502, 2010
• Y. Piao, J. Liang, L. Holmes, V. Henry, E. Sulman, and J. F. de Groot, "Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition" Clinical Cancer Research, vol. 19, no. 16, pp. 4392-4403, 2013
• A. Sottoriva, I. Spiteri, S. G. M. Piccirillo et al., "Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics" Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 110, no. 10, pp.4009-4014, 2013
• T. Ozawa, M. Riester, Y. Cheng et al., "Most humannon-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma" Cancer Cell, vol. 26, no. 2, pp. 288-300, 2014
• A. Balbous, U. Cortes, K. Guilloteau et al., "A mesenchymal glioma stem cell profile is related to clinical outcome" Oncogenesis, vol. 3, no. 3, article e91, 2014
• C. Muller, J. Holtschmidt, M. Auer et al., "Hematogenous dissemination of glioblastoma multiforme" Science Translational Medicine, vol. 6, no. 247, Article ID 247ra101, 2014
• K. M. MacArthur, G. D. Kao, S. Chandrasekaran et al., "Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay" Cancer Research, vol. 74, no. 8, pp. 2152-2159, 2014
• J. Song, C. Wu, E. Korpos et al., "Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokineinduced leukocyte migration" Cell Reports, vol. 10, no. 7, pp. 1040-1054, 2015
• C. P. Hofstetter, J.-K. Burkhardt, B. J. Shin et al., "Protein phosphatase 2A mediates dormancy of glioblastoma multiformederived tumor stem-like cells during hypoxia" PLoS ONE, vol. 7, no. 1, Article ID e30059, 2012
• G. A. Alexiou, G. Vartholomatos, A. Karamoutsios, A. Batistatou, A. P. Kyritsis, and S. Voulgaris, "Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma" Acta Neurologica Belgica, vol. 113, no. 1, pp. 7-11, 2013
• L. Ricci-Vitiani, R. Pallini, M. Biffoni et al., "Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells" Nature, vol. 468, no. 7325, pp. 824-830, 2010